Boletín de la Sociedad Peruana de Medicina Interna - Vol. 12 Nº1 - 1999

 

BIBLIOGRAFÍA

  • American Diabetes Association. Report of the Expert Committe on the Diagnosis and Clasification of diabetes Mellitus. Diabetes Care 1997; 20:1187 - 1197.

  • Asociación Latinoamericana de Diabetes. Consenso sobre Prevención, control y Tratamiento de la Diabetes Mellitus No Insulinodependiente Bs. As., Ediciones Mayo 1995.
  • Durruty P, Carrasco E, García M y López G. Hemoglobina glucosilada y secreción insulínica en obesos con intolerancia a la glucosa. Rev. Med. Chile 1998; 116:993-997.
  • Foster D. Diabetes Mellitus. En Isselbacher K, Braunwald E, Wilson J y cols. Harrison: Principios de Medicina interna. 13a. DE., Madrid Interamericana Mc. Graw-Hill. 1994: 2281-2305.
  • Sir. T, López G, Castillo T y cols. Marcadores bioquímicos y métodos de cuantificación de insulinorresistencia en mujeres normales, obesas e hiperandrogénicas. Rev Méd Chile 1997; 125: 977-985.
  • Skiler J. Glucose control in type 2 diabetes mellitus Ann Intern Med 1997; 127: 837-838.
  • Turner R, Cull C and Holman R. United Kingdom Prospective Diabetes Study: A 9- year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med 1996:136-145.
  • Valdivia H. Diagnóstico y control de la diabetes mellitus. Diagnóstico 1998; 37: 74-82
  • Villena, J. Tratamiento de la diabetes mellitus tipo 2. Diagnóstico 1998; 37:95?110
  • rland M. Diabetes Mellitus. En Ewald G y McKenzie C. Manual de Terapéutica Médica Washington University, 9a Ed., Barcelona, Masson-Little Blow S.A. 1996: 519-550.
  • Olefsky J. Diabetes Sacarina. En Wyngaarden J, Smith L y Bennett J, Cecil:Tratado de Medicina Interna 19a Ed., México, Interamericana Mc.Graw-Hill, 1994: 1503-1525.
  • Barrett-Connor E, Khaw KT, Yen S. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med 1986; 315: 1519-1524
  • Baulieu EE. Dehydroepiandrosterone (DHEA): A Fountain of Youth- J Clin Endocrinol Metab 1996; 81: 3147-3151.
  • Parker L. Adrenal Androgens. In DE Groot L. Endocrinology. 3rd Ed., Philadelphia, W.B. De Saunders Company, 1995: 1836-1851.
  • Herbert J. La era de la dehidroepiandrosterona. The Lancet (Ed. en español) 1995; 27:209-210.
  • Quiroz G, ed La dehidroepiandrosterona: Un enigma presto a ser revelado. Medicina Contemporánea 1997; 5: 32-35.
  • Assan. R, Robel P, Baulieu EE Dehydroepian-drosterone (DHEA) for diabetic patients?, Eur J Endocrinol 1996; 135: 37-38.
  • Beer N, Jakubowicz D, Beer et al. Effects of nitradipine on glucose tolerance and serun insulin and dehydroepiandrosterone sulfate levels in insuli-resistant obese and hypertensive men. J Clin Endocrinol Metab 1993; 76: 178-183.
  • Davies L, Pryo K, Twigg S et al. Any association between low serum DHEAS levels and ischaemic heart disease in NIDDM is negated by age. 16th international Diabetes Federation Congress Abstracts, Diabetologia Supplement 1997, N° 1730.
  • Denti L, Pasolini G, Sanfelici L, et al. Effects of aging on dehydroepiandrosterone sulfate in relation to fasting insulin levels and body composition assessed by bioimpedance analysis. Metabolism 1997; 46: 826-832.
  • Hamano K, Ajima M, Okazaki R. and Totsuka Y. The roles of DHEA and DHEAS in NIDDM patients: A possible modulator of glucose metabolism. 16th International Diabetes Federation Congress Astracts, Diabetologia Supplement 1997; N° 1154.
  • Herranz L, Megia A, Grande C et al. Dehydroepiandrosterone sulphate, body fat distribution and insulin in obese men. Int J Obes Relat Metab Disord 1995; 19: 57-60
  • Lavalleé B, Provost P, Khawash Z et al. Effect of insulin or serum levels of  dehydroepiandrosterone metabolites in men. Clin Endocrinol Oxf 1997; 46: 93-100.
  • Loviselli A, Pisanu P, Cossu E et al. Low levels of dehydroepiandrosterone sulfate in adult males with insulindependent diabetes mellitus. Minerva Endocrinol 1994; 19: 113-119.
  • Nestler J and McClanahan M. Diabetes and adrenal disease. Baillieres Clin Endocrinol Metab 1992; 6: 829-847.
  • Paolisso G, Ammendola S, Rotondi M et al. Insulin resistance and advancing age: What role for dehydroepiandrosterone sulfate-. Metabolism 1997; 46: 1281-1286.
  • Slowinska-Sezednicka J, Malczewsk B, Srzednicki M et al. Hyperinsulinaemia and decreased plasma levels of dehydroepiandrosterone sulfate in premenopausal women with coronary disease. J Intern Med 1995; 237: 465-472.
  • Iizuka T, Miyamoto T, ItoH et al Relationship between DHEA-S and insulin sensitivity in patients with non-insulin dependent diabetes mellitus 16th international Diabetes Federation Congress Abstracts, Diabetologia Suplement 1997, N° 1174
  • Aronne L. Obesity. Medical Clinics of North America 1998; 82: 161-181.
  • Bjorntorp P. Obesidad. The Lancet (Ed. en español) 1997; 31: 376-379.
  • De pergola G, Triggiani V, Giorgino F et al. The Testosterone to dehydroepiandrosterone sulphate molar ratio as a marker of visceral fat accumulation in premenopausal obese women. Int J Obes relat Metab Disord 1994; 18: 659-664.
  • Farrearas P y Rozman C. Medicina Interna 13a Ed., Mosby/ Doyma Libros, 1995.
  • Jover E. Indice cintura/cadera. Obesidad y riesgo cardiovascular. An Med Intern (Madrid) 1997; 14: 9- 10.
  • Maggio C. and Pi-Sunyer F. The prevention and treatment of obesity. Application to type 2 diabetes. Diabetes Care 1997; 20: 1744-1766.
  • Okamoto K. Yagyu K and Sasaki R. The relationship between serum dehydroepiandrosterone sulfate levels and factors associated with cardiovascular diseases: A cross-sectional study in Japan. Nippon Koshu Eisei Zasshi 1995: 42: 78-83.
  • Seclén S. Avances en el tratamiento de la diabetes mellitus no    insulino dependiente. Diagnóstico 1996; 35:26-33.
  • Fletcher P, Aguila J y Villanueva J. Valores normales en Panamá de dehidroepiandrosterona sulfato sérico por radioinmunoanálisis. Rev. Méd Caja Seguro Soc 1985; 17: 229-232.
  • Labrie F, Bélanger A, Cusan L et al. Marked decline in serum concentrations of adrenal C 19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 1997; 82: 2396-2402.
  • Sulcová J, Hill M, Hampl R and Stárka L. Age and sex related differences in serum levels of unconjugated dehydroepiandrosterone and its sulphate in normal subjects J Endocrinol 1997; 154:57-62.
  • Yamauchi A, Takei I, Kasuga A, et al. Depression of dehydroepiandrosterone in Japanese diabetic men - comparison between non-insulin-dependient diabetes mellitus and impaired glucose tolerance. Eur J Endocrinol 1996; 135: 101-104.